Beauchamp, Geetha http://orcid.org/0000-0001-6721-3930
Hosek, Sybil
Donnell, Deborah
Chan, Kwun C. G.
Anderson, Peter L.
Dye, Bonnie J.
Mgodi, Nyaradzo
Bekker, Linda-Gail
Delany-Moretlwe, Sinead
Celum, Connie
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
The Effect of Disclosure of PrEP Use on Adherence Among African Young Women in an Open-Label PrEP Study: Findings from HPTN 082
https://doi.org/10.1007/s10461-023-04175-0
High prevalence and incidence of gonorrhoea and chlamydia in young women eligible for HIV pre-exposure prophylaxis in South Africa and Zimbabwe: results from the HPTN 082 trial
https://doi.org/10.1136/sextrans-2022-055696
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (UM1-AI068617)
Article History
Accepted: 9 September 2023
First Online: 28 September 2023
Declarations
:
: The HPTN 082 study was supported by award numbers UM1AI068619, UM1AI068613, UM1AI1068617 from the NIH (National Institute of Allergy and Infectious Diseases [NIAID]) to HPTN. This manuscript work was funded by UM1AI1068617. The content is solely the authors’ responsibility and does not necessarily represent the official views of the National Institutes of Health.
: The HPTN 082 parent study received institutional review boards (IRB) approval from each study site: University of Cape Town Faculty of Health Sciences (reference number: 129/2016), University of Witwatersrand, Human Research Ethics Committee (reference number: 160304), and University of Zimbabwe Joint Research Ethics Committee (reference Number: 27/16). All participants provided written informed consent in English or their local language. Following local regulations, participants below the legal age for consent provided assent, and parent or guardian informed consent was obtained.